Drug Delivery Business6d
Real-world data backs Insulet Omnipod 5 in children
A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...
Hosted on MSN8mon
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
Presently, Omnipod 5 is FDA-cleared in the United States and C.E. marked for use in those with type 1 diabetes aged two years and older. More on the Omnipod 5 Study ...
Morningstar14d
Insulet's Distinctive Omnipod Pump Makes Inroads With Large Type 2 Diabetes Segment
With little direct competition in patch pumps, Insulet has been able ... Insulet continues to see adoption of its Omnipod 5 pump—the device that represents Insulet's entrance into hybrid closed ...
Hosted on MSN3mon
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Image Source: Zacks Investment Research The full U.S. market release of Omnipod 5 with Dexcom’s G7 CGM took place in June this year. Expanding global access to Omnipod 5 has been one of the top ...